View of A pilot study to evaluate the efficacy and safety of prophylactic Romiplostim in preventing Grade 4 thrombocytopenia in multiple myeloma and lymphoma patients undergoing Autologous stem cell transplant

Return to Article Details A pilot study to evaluate the efficacy and safety of prophylactic Romiplostim in preventing Grade 4 thrombocytopenia in multiple myeloma and lymphoma patients undergoing Autologous stem cell transplant Download Download PDF